Paolo Bellantonio

913 total citations
11 papers, 247 citations indexed

About

Paolo Bellantonio is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Paolo Bellantonio has authored 11 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 4 papers in Neurology and 2 papers in Oncology. Recurrent topics in Paolo Bellantonio's work include Multiple Sclerosis Research Studies (9 papers), Systemic Lupus Erythematosus Research (2 papers) and Vestibular and auditory disorders (2 papers). Paolo Bellantonio is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Systemic Lupus Erythematosus Research (2 papers) and Vestibular and auditory disorders (2 papers). Paolo Bellantonio collaborates with scholars based in Italy, Serbia and Lebanon. Paolo Bellantonio's co-authors include Diego Centonze, Roberta Fantozzi, Roberto Furlan, Ennio Iezzi, Mario Stampanoni Bassi, Luana Gilio, Fabio Buttari, Annamaria Finardi, Francesco Sica and Georgia Mandolesi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Neurochemistry and Clinical Neurophysiology.

In The Last Decade

Paolo Bellantonio

11 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paolo Bellantonio Italy 8 171 45 39 37 36 11 247
Heinz Wiendl Germany 8 114 0.7× 33 0.7× 34 0.9× 35 0.9× 51 1.4× 20 257
Nadia Tenenbaum United States 11 234 1.4× 80 1.8× 51 1.3× 19 0.5× 90 2.5× 21 369
Laura Ferrè Italy 10 191 1.1× 36 0.8× 55 1.4× 31 0.8× 91 2.5× 26 280
Mariangela D’Onghia Italy 10 226 1.3× 44 1.0× 69 1.8× 79 2.1× 82 2.3× 14 296
David K. Li Canada 7 169 1.0× 43 1.0× 48 1.2× 70 1.9× 119 3.3× 9 332
Robert A Bermel United States 7 271 1.6× 36 0.8× 63 1.6× 62 1.7× 124 3.4× 12 349
Lucía Alonso-Magdalena Sweden 9 107 0.6× 27 0.6× 42 1.1× 22 0.6× 27 0.8× 16 204
Alaa Elmazny Egypt 11 128 0.7× 57 1.3× 20 0.5× 13 0.4× 79 2.2× 33 304
Luigina Musu Italy 10 206 1.2× 46 1.0× 33 0.8× 72 1.9× 55 1.5× 10 299
Carmen Lienert Switzerland 8 162 0.9× 24 0.5× 32 0.8× 35 0.9× 47 1.3× 12 245

Countries citing papers authored by Paolo Bellantonio

Since Specialization
Citations

This map shows the geographic impact of Paolo Bellantonio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Bellantonio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Bellantonio more than expected).

Fields of papers citing papers by Paolo Bellantonio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Bellantonio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Bellantonio. The network helps show where Paolo Bellantonio may publish in the future.

Co-authorship network of co-authors of Paolo Bellantonio

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Bellantonio. A scholar is included among the top collaborators of Paolo Bellantonio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Bellantonio. Paolo Bellantonio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Zanghì, Aurora, Simonetta Galgani, Paolo Bellantonio, et al.. (2023). Relapse‐associated worsening in a real‐life multiple sclerosis cohort: the role of age and pyramidal phenotype. European Journal of Neurology. 30(9). 2736–2744. 2 indexed citations
2.
Bassi, Mario Stampanoni, Luana Gilio, Ennio Iezzi, et al.. (2021). Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis. Frontiers in Aging Neuroscience. 13. 694651–694651. 8 indexed citations
3.
Bassi, Mario Stampanoni, Tommaso Nuzzo, Luana Gilio, et al.. (2021). Cerebrospinal fluid levels of L‐glutamate signal central inflammatory neurodegeneration in multiple sclerosis. Journal of Neurochemistry. 159(5). 857–866. 11 indexed citations
4.
Bassi, Mario Stampanoni, Jelena Drulović, Tatjana Pekmezović, et al.. (2020). Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients. Therapeutic Advances in Neurological Disorders. 13. 1279192401–1279192401. 6 indexed citations
5.
Bassi, Mario Stampanoni, Fabio Buttari, Andrea Sancesario, et al.. (2019). Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patients. Clinical Neurophysiology. 131(2). 566–573. 12 indexed citations
6.
Bassi, Mario Stampanoni, Ennio Iezzi, Fabio Buttari, et al.. (2019). Obesity worsens central inflammation and disability in multiple sclerosis. Multiple Sclerosis Journal. 26(10). 1237–1246. 100 indexed citations
7.
Bellantonio, Paolo, et al.. (2017). Morphological description of hypothetical cellulite starting unit. The first step to explain cellulite development. 1 indexed citations
8.
Totaro, Rocco, Gianfranco Costantino, Roberta Fantozzi, et al.. (2015). Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study. SHILAP Revista de lepidopterología. 2015. 1–7. 25 indexed citations
9.
Lugaresi, Alessandra, Ciro Florio, Vincenzo Brescia Morra, et al.. (2012). Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study. BMC Neurology. 12(1). 7–7. 52 indexed citations
10.
Lugaresi, Alessandra, Placido Bramanti, Maria Pia Amato, et al.. (2011). Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients. Journal of Translational Medicine. 9(1). 42–42. 10 indexed citations
11.
Millefiorini, Enrico, Antonio Cortese, S. Di Rezze, et al.. (2010). The prevalence of multiple sclerosis in central Italy. Multiple Sclerosis Journal. 16(12). 1432–1436. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heinz Wiendl Breakdown of academic impact, for papers by Nadia Tenenbaum Breakdown of academic impact, for papers by Laura Ferrè Breakdown of academic impact, for papers by Mariangela D’Onghia Breakdown of academic impact, for papers by David K. Li Breakdown of academic impact, for papers by Robert A Bermel Breakdown of academic impact, for papers by Lucía Alonso-Magdalena Breakdown of academic impact, for papers by Alaa Elmazny Breakdown of academic impact, for papers by Luigina Musu Breakdown of academic impact, for papers by Carmen Lienert
Rankless by CCL
2026